摘要
目的观察参麦注射液联合贝那普利治疗慢性阻塞性肺疾病(COPD)合并慢性肺源性心脏病(CPHD)的临床效果。方法选取2016年1月至2017年10月河南省人民医院收治的79例COPD合并CPHD患者,按随机数表法分为A、B两组。A组患者在常规治疗的基础上服用贝那普利,B组在A组治疗的基础上接受参麦注射液辅助治疗。对比两组患者治疗前后LVEF、CO和FEV1、FVC%水平,统计两组患者治疗总有效率和不良反应发生率。结果 B组患者治疗后LVEF、CO水平和FEV1、FVC%水平均高于A组(P <0. 05); B组患者治疗总有效率(97. 50%)高于A组(84. 62%),差异有统计学意义(P <0. 05);两组患者均未发生明显不良反应。结论参麦注射液联合贝纳利普治疗COPD合并CPHD临床疗效较好,可有效改善患者心肺功能,具有临床推广价值。
Objective To observe the clinical effect of shenmai injection combined with benazepril in the treatment of chronic obstructive pulmonary disease(COPD)combined with chronic pulmonary heart disease(CPHD).MethodsSeventy-nine patients with COPD combined with CPHD admitted to Henan Provincial People's Hospital from January of 2016 to October of 2017 were randomly divided into two groups.Patients in group A were treated with benazepril on the basis of conventional treatment,while patients in group B were treated with ginseng injection on the basis of the treatment of group A.The levels of LVEF,CO,FEV1 and FVC%before and after treatment were compared between the two groups,and the total effective rate of the two groups was statistically calculated.ResultsAfter treatment,LVEF,CO,FEV1 and FVC%in group B were higher than those in group A(P<0.05).The total therapeutic efficiency of group B(97.50%)was higher than group A(84.62%),and the difference was statistically significant(P<0.05).No adverse reaction was observed in both groups.ConclusionShenmai injection combined with benazepril has a better clinical efficacy in the treatment of COPD with CPHD,can effectively improve the cardiopulmonary function of patients,deserves the clinical expansion.
作者
田二虎
程江涛
Tian Erhu;Cheng Jiangtao(Department of Cardiology,Henan Provincial Peoples Hospital,Zhengzhou 450000,China)
出处
《中华心脏与心律电子杂志》
2018年第1期7-9,共3页
Chinese Journal of Heart and Heart Rhythm(Electronic Edition)
基金
国家自然科学基金项目(H2902)
关键词
慢性阻塞性肺疾病
慢性肺源性心脏病
参麦注射液
贝那普利
Chronic obstructive pulmonary disease
Chronic pulmonary heart disease
Shenmai injection
Benazepril